microscopy. These findings demonstrate that chemokine receptors can affect T-APC synapse stability and allow us to propose a novel mechanism that contributes to the adaptive immune response defects in WHIM patients.
Introduction
The rare human WHIM syndrome is characterized by neutropenia, myelokathexis, delayed antibody class switching to Immunoglobulin G (IgG) 1 , long-term hypogammaglobulinemia and memory B cell lymphopenia, 2 recurring infections and human papillomavirus-induced warts. 3 WHIM is associated with C-terminal, dominant mutations in the chemokine receptor CXCR4, resulting in truncation of the receptor. 4 This leads to defective recycling upon binding of the CXCR4 ligand, CXCL12, and thus increased responsiveness to CXCL12 stimulation. 2, 5, 6 The hyperfunctional CXCR4 mutations may thus explain neutrophil retention in the bone marrow (myelokathexis), where CXCL12 is expressed, 7 and the consequent neutropenia in the periphery. 8 However, the mechanism of pathogenesis of the remaining WHIM symptoms is less clear. The resultant memory B cells and plasma cells subsequently migrate to their niches. 1 For personal use only. at BIBLIOTECA POLO SAN PAOLO on July 3, 2013. bloodjournal.hematologylibrary.org From It has been proposed that, in a manner analogous to the effect on neutrophils, WHIMmutant CXCR4 on B cells may account for both the initial delay in mounting an IgG antibody response and the long-term memory B cell dysfunction, by affecting the homing of the B cells. 1 We have previously demonstrated that chemokine receptors, in addition to controlling leukocyte homing and migration, may increase the stability of the T cell-APC immunological synapses, 10 the specialized junctions that form at the initiation of adaptive immune responses and which are necessary for successful T cell activation. 11, 12 Indeed, in vitro studies have led to the hypothesis that chemokines in lymph nodes may either enhance the stability of the synapse -by reinforcing the "stop" signal transduced by the antigen-triggered T cell receptor (TCR)-or inhibit T-APC interactions -by providing "go" signals overcoming the TCR-. [13] [14] [15] Whether this regulates T cell activation in vivo is still unknown.
Given the hyperfunctional nature of WHIM-mutant CXCR4, 2, 5 we hypothesized that the WHIM-associated mutations in CXCR4 may interfere with the robustness of the T cell-APC synapses. This would be expected to affect T cell activation, as well as the B cell functions that are dependent on T cell activation, such as immunoglobulin class switching. Here we show that the WHIM-associated mutations of CXCR4 impair T-APC synapse stability and may be affecting T cell priming, while causing a delay in IgG responses. These findings identify a novel mechanistic explanation for the defects in the early stages of adaptive immune responses in the WHIM syndrome, whilst also offering a novel and natural demonstration of the role of chemokines in the regulation of the immunological synapse stability.
For personal use only. at BIBLIOTECA POLO SAN PAOLO on July 3, 2013. bloodjournal.hematologylibrary.org From
Methods

Retrogenic mice
Animals were kept in an SPF facility and treated according to Institutional and National guidelines and regulations. Retrogenic mice were created as in 16 : bone marrows (BM) were harvested from donor OT-II ovalbumin (OVA)-specific TCRtransgenic CD45.1 mice, that had been pre-treated with 5-fluoracil at 5.5mg/25g mouse, 4 days prior to harvesting. Harvested BM cells were grown in 20ng/ml rmIL-3, 50ng/ml rmIL-6 and 50ng/ml rmSCF (all R&D Systems) for 48h and then transduced with retroviral vectors for EGFP-WT-CXCR4 or EGFP-WHIM-CXCR4
and pCLEco (Imgenex) on day 2, 3 and 4 post-BM harvesting, using fresh viral supernatants, as in 17 . The transduced BM cells were kept in culture for a further 2 days prior to intravenous injection into irradiated (2x475 Rad) C57BL/6 recipients.
These recipients were used as retrogenic mice, 7 weeks post-intravenous injection.
T cell purification
Patient and healthy donor samples were obtained after informed consent at Clinica Pediatrica and Humanitas, according to the institutional ethical committee guidelines and the Declaration of Helsinki. Primary human CD4 + T cells from peripheral blood were isolated using RosetteSep (StemCell Technologies), at a typical purity of >90%.
CD4
+ T cells were transduced with CXCR4 constructs using Amaxa human T cell nucleofector (Lonza). For experiments with patient samples, PBMC from WHIM patients and healthy age/gender-matched donors where expanded for 2 weeks after activation with 2.5 μg/ml PHA (Biochrom AG), 400 U/ml IL-2 (Chiron) and irradiated feeders; CD4 + T cells were then isolated using a FACSAria (BD) cell effects of the two dyes could affect measurements. As this necessitated imaging of the 2 populations in consecutive slices, the same Blue-CMAC-labeled, non-retrogenic control population was used as an internal control in both cases.
T cell-APC conjugates
The conjugate stability assay by transwell migration and the analysis of receptor recruitment to the synapse were adapted from 10 , with the following modifications:
conjugates were formed between WT or WHIM-mutant CXCR4-expressing CD4 + T and primary B cells obtained via RosetteSep (StemCell Technologies). B cells had been pulsed with superantigen (1μg/ml staphylococcal enterotoxin A/B/E, Toxin Technology) and labeled with PKH26 dye (Sigma) and were used at a 1:1 ratio with T cells. Cells were then allowed to migrate through 3μm pores to 2.5nM CXCL12
(R&D Systems) for 2h, before analyzing by FACS. Conjugates prepared for confocal microscope analysis of receptor recruitment were made using EBV-B as APC, and allowed to form in the presence or absence of CXCL12 (5nM-100nM) and AMD3100
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Two-photon microscopy imaging
Lymph node slice preparation was adapted from 18 . Bone marrow-derived dendritic cells (DC) were pulsed with 10μg/ml OVA(323-339)(Anaspec), labeled with 5μM , the lymph node slices were placed in AMD3100 (Sigma, 12.6μM); to avoid the reported inhibition of entry into the lymph node slice, T cells were allowed 30 min in AMD3100-free medium to enter to the lymph node, followed by 30 min incubation in the presence of the inhibitor. AMD3100 was also present in the perfusion medium.
Image analysis was performed on Imaris (Bitplane), using manually-corrected automatic tracking, and manual calculation of T-DC interaction times.
Activation experiments
T cell priming was performed by injecting 500ng OVA peptide in CFA into each hind footpad of WT or WHIM retrogenic mice. Draining lymph nodes and spleen were analyzed by FACS 12h after injection, for the expression of EGFP and staining for CD45.1 (A20; eBiosciences), CD4 (GK1.5; BioLegend) and CD69 (H1.2F3; BD). 10 . For mouse in vitro APCfree T cell activation, 2μg/ml anti-CD3e (145-2C11; BD) and 1μg/ml anti-CD28
(37.51; BD) were used for coating flat-bottom 96 well plates. The activation of rgWT and rgWHIM T cells by DC (at a 2:1 ratio) in the presence or absence of 25nM CXCL12 in the lower chamber of transwell assay plates was analyzed by FACS after staining for CD25 (PC61.5; eBiosciences).
Results
WHIM-mutant CXCR4 disrupts the stability of T cell-APC conjugates in WHIM patients
Given the association of the WHIM-mutant CXCR4 with enhanced chemotactic properties, 2, 5 we decided to assess whether the mutant chemokine receptor could impair the stability of the T-APC interaction in WHIM patients. Peripheral blood CD4 + T cells purified from a WHIM patient (G336X) or a healthy age-and gendermatched donor were used in conjugate stability experiments. 10 T cells were allowed to form conjugates with labeled, superantigen-pulsed primary B cells. Non-pulsed B cells, which cannot form successful T-B conjugates, were used as controls. The conjugates were then allowed to migrate in a transwell assay towards CXCL12, using a transwell filter pore size allowing only single cells to pass through. The number of migrated CD4 + T cells is thus an indication of lack of conjugate stability. 10 As expected, T cells from healthy donors were significantly impaired from migrating to CXCL12 when superantigen-pulsed B cells were used for conjugate formation,
suggesting that "go" signals delivered by wild-type (WT) CXCR4 are subordinate to the "stop" signal delivered by the antigen-triggered TCRs ( Figure 1A , left panel), in agreement with previous in vitro studies. 13 However, under the same conditions, the For personal use only. at BIBLIOTECA POLO SAN PAOLO on July 3, 2013. bloodjournal.hematologylibrary.org From
Expression of WHIM-mutant CXCR4 disrupts the stability of T cell-APC conjugates in healthy donor cells
To prove that this is indeed due to the mutant CXCR4, we cloned the WT and WHIM-mutant (R334X) versions of CXCR4 fused with Enhanced Green Fluorescent Protein (EGFP). The ectopically expressed receptor was functional, as it could lead to phosphorylation of MAP kinases after CXCL12 administration (data not shown).
Importantly, the WHIM-mutant CXCR4 was refractive to ligand-induced internalization (supplemental Figure 1) , which is a hallmark of the WHIM syndrome. 5, 6 We expressed WT or WHIM-mutant CXCR4 in primary CD4 + T cells from healthy donors and used them in conjugate stability experiments, as above. As the WHIM mutation is dominant, 3 endogenous WT CXCR4 expression in transfected cells is unlikely to interfere with the experimental outcome. CXCL12 was able to break conjugates formed with T cells expressing the WHIM-mutant but not with WT CXCR4 ( Figure 1B ). This demonstrates that the WHIM-mutant CXCR4 per se has destabilizing effects on the immunological synapse when exposed to competing cognate chemokine. As CXCL12 is present in the lymph node environment 21 this "distracting" effect could impact on physiological T cell activation.
WHIM-mutant CXCR4 affects T cell-APC long-lasting interactions
To assess the physiological relevance of our findings, we tested our hypothesis utilizing ex vivo organ cultures of mouse lymph node slices. 18, 22 As human CXCR4 is functional in mice, 8 we created retroviral versions of the CXCR4 constructs described above and used them to make retrogenic mice 16 for WT or WHIM-mutant CXCR4.
These mice generate mature, unactivated ovalbumin(OVA)-antigen-specific T cells expressing WT or WHIM-mutant CXCR4, 6 weeks after reconstitution of irradiated recipients with transduced bone marrow cells 16, 23 (see Methods).
The WHIM retrogenic mice showed a 4-fold increase in bone marrow retention of WHIM-mutant CXCR4-expressing leukocytes in sentinel animals (data not shown), similar to previously reported models. 8 Nonetheless, the mice ought to be considered as "retrogenic cell generators" rather than disease models. As the observed impairment could be due to defective development of the rgWHIM T cells, we repeated the above experiments in the presence of AMD3100, a CXCR4 inhibitor that is identical to FDA and EMEA approved drug plerixafor. 25 In the presence of AMD3100, rgWHIM cells no longer differed from rgWT cells in the proportion of long-lasting interactions ( Figure 3A ; also plotted as % in Figure 3B ; Video 6). Thus, the defective T-DC conjugate stability of rgWHIM cells was reversible within the lymph node slice and is therefore unlikely to be caused by upstream developmental defects. Although at very high concentrations, not achievable in vivo with the maximum FDA-approved dose, AMD3100 may act as a CXCR7 agonist, 26 the complete reversal of the phenotype caused by the mutant CXCR4
suggests that, in this context, AMD3100 does indeed act as a CXCR4 inhibitor. Cells expressing WT CXCR4 were expectedly unaffected, as it has been shown that WT CXCR4 signaling within the lymph node microenvironment is inconsequential for T cell activation.
18,27
The recruitment of WHIM-mutant CXCR4 to the Immunological Synapse is disrupted by competing chemokine signals
In order to gain insight on the mechanism that underlies the disruption of synapse stability by WHIM-mutant CXCR4, we examined the cellular distribution of the 
WHIM-mutant CXCR4 leads to aberrant in vivo T cell priming and a delayed
IgG response
Even though not all stable T-APC conjugates would be expected to lead to the initiation of an immune response, a significant impairment in the stability of immunological synapses is likely to cause aberrant T cell activation in vivo. 11, 12 To test this in our system, we injected OVA peptide into the footpads of WHIM-mutant To confirm the physiological relevance of our findings, we assessed whether the aberrant T cell priming could lead to T cell-dependent early activation defects that characterize WHIM syndrome patients, such as the delay in IgG responses found in one study. 1 To this end, we transferred 25X10 3 OVA-specific rgWT or rgWHIM 30 even though studies of hypogammaglobulinemia have yet to be performed in the latter. 31 Given the wide expression range of CXCR4, it is likely that the combined effect of the above mechanisms, including the defect in synapse stability described here, contribute to the complex symptoms of the WHIM syndrome.
In the physiological milieu where T-APC immunological synapses form, "dominant" chemokine signaling has been proposed to inhibit stable synapse formation, based on results of in vitro experimentation.
14,15 CXCL12 interacting with T cells expressing WT CXCR4 was found not to be a "dominant" chemokine. 13 Rather, CXCR4 is recruited to the immunological synapse itself, where it enhances the activation of the T cell after receiving chemokine ligand produced by the APC. 10 Exogenous chemokine signals that are not derived from the APC but from the surrounding lymph node microenvironment, where the chemokine is present, 21 indeed did not affect T-APC synapse formation in WT CXCR4-expressing cells in our studies, in agreement with results showing lack of a role for WT CXCR4-CXCL12 on T cell activation. 18 ,27
Yet our in vitro and ex vivo results show that WHIM-mutant CXCR4 enables CXCL12 to act as a distracting, "dominant" chemokine. This appears to occur via the disruption of the recruitment of WHIM-mutant CXCR4 to the synapse. Both the disruption of the receptor recruitment to the synapse and the "distracting" of stable synapse formation appear to be reversible by AMD3100 treatment, which has recently been proposed as a therapeutic agent for the WHIM syndrome. 25 Importantly, our findings also provide the first physiological, ex vivo evidence that chemokines and their receptors may control the stability of T-DC interactions in lymph nodes. The data suggest the existence of a delicate equilibrium between adhesive and chemoattractant forces operating in lymph nodes during T cell priming, allowing enough motility for T cell repertoire scanning whilst ensuring the formation of longlasting conjugates, once a cognate T-APC pair is formed. Variations in this equilibrium, such as those due to the hyperfunctional mutant CXCR4 of WHIM It is noteworthy that, in the absence of antigen, the rgWHIM T cells displayed a higher baseline CD25 expression. For personal use only. at BIBLIOTECA POLO SAN PAOLO on July 3, 2013. bloodjournal.hematologylibrary.org From
